Lupus;Kidney;Nephritis;Clinical Research;Antibody Therapy;Immune Response

Obinutuzumab shows promise in lupus nephritis trial

[ad_1] Newswise — In a post hoc analysis of the phase 2 NOBILITY trial, researchers found that treatment with obinutuzumab—an…